319906-53-1 Usage
Uses
Used in Pharmaceutical Industry:
Carbamic acid, [(3S,4R)-4-methyl-3-pyrrolidinyl]-, 1,1-dimethylethyl ester (9CI) is used as a drug delivery agent for enhancing the solubility, stability, and bioavailability of pharmaceutical compounds. Its ability to form stable liquid crystalline phases allows for controlled release of drugs, improving their therapeutic efficacy and reducing side effects.
Used in Chemical Industry:
In the chemical industry, Carbamic acid, [(3S,4R)-4-methyl-3-pyrrolidinyl]-, 1,1-dimethylethyl ester (9CI) is used as an intermediate in the synthesis of various chemical compounds. Its unique properties, such as forming stable liquid crystalline phases, make it a valuable component in the development of new materials and products.
Used in Drug Delivery Systems:
Carbamic acid, [(3S,4R)-4-methyl-3-pyrrolidinyl]-, 1,1-dimethylethyl ester (9CI) is employed in the development of novel drug delivery systems, such as nanoparticles and liposomes, to improve the targeting and efficiency of drug administration. Its amphiphilic nature allows for the formation of stable structures that can encapsulate and protect drug molecules, ensuring their controlled release at the desired site of action.
Check Digit Verification of cas no
The CAS Registry Mumber 319906-53-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,9,9,0 and 6 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 319906-53:
(8*3)+(7*1)+(6*9)+(5*9)+(4*0)+(3*6)+(2*5)+(1*3)=161
161 % 10 = 1
So 319906-53-1 is a valid CAS Registry Number.
319906-53-1Relevant articles and documents
Isoindoline derivatives
-
, (2008/06/13)
Optically active 8-methoxyquinolonecarboxylic acids represented by the formula (I) wherein R1 is lower alkyl have been found to possess potent antibacterial activity against both Gram-negative and Gram-positive bacteria. The compounds may be synthesized from novel optically active intermediates.